Modulation of IFI30 expression to break off the pathway for MHC-restricted tumor antigen presentation has been proven to contribute to malignant cells evading T-cell surveillance of the immune system (Seliger et al., 2000; Haque et al., 2002). The gene discussed is IFI30; the disease is neoplasm.